Writing and erasing MYC ubiquitination and SUMOylation

by Yingxiao Chen, Xiao-Xin Sun, Rosalie C. Sears, Mu-Shui Dai
Published 2019-12-01

Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy

by Xiao-Xin Sun, Yanping Li, Rosalie C. Sears, Mu-Shui Dai
Published 2021-06-01

Molecular Crosstalk Between MYC and HIF in Cancer

by Yanping Li, Xiao-Xin Sun, David Z. Qian, Mu-Shui Dai, Mu-Shui Dai
Published 2020-11-01

Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.

by Xiao-Hong Shu, Hong Li, Xiao-Xin Sun, Qian Wang, Zheng Sun, Mo-Li Wu, Xiao-Yan Chen, Chong Li, Qing-You Kong, Jia Liu
Published 2011-01-01

Publisher Correction: Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy

by Hao Geng, Changhui Xue, Janet Mendonca, Xiao-Xin Sun, Qiong Liu, Patrick N. Reardon, Yingxiao Chen, Kendrick Qian, Vivian Hua, Alice Chen, Freddy Pan, Julia Yuan, Sang Dang, Tomasz M. Beer, Mu-Shui Dai, Sushant K. Kachhap, David Z. Qian
Published 2019-01-01

Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy

by Hao Geng, Changhui Xue, Janet Mendonca, Xiao-Xin Sun, Qiong Liu, Patrick N. Reardon, Yingxiao Chen, Kendrick Qian, Vivian Hua, Alice Chen, Freddy Pan, Julia Yuan, Sang Dang, Tomasz M. Beer, Mu-Shui Dai, Sushant K. Kachhap, David Z. Qian
Published 2018-11-01